Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0MUFS | ISIN: KYG8813K1085 | Ticker-Symbol: UNJ
Frankfurt
06.06.25 | 17:15
1,660 Euro
0,00 % 0,000
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
UNITED LABORATORIES LTD Chart 1 Jahr
5-Tage-Chart
UNITED LABORATORIES LTD 5-Tage-Chart
RealtimeGeldBriefZeit
1,6301,78006.06.

Aktuelle News zur UNITED LABORATORIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
30.04.UNITED LAB (03933): 2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT1
UNITED LABORATORIES Aktie jetzt für 0€ handeln
29.04.UNITED LAB (03933): NOTIFICATION LETTER TO NON-REGISTER HOLDER AND REPLY FORM-
29.04.UNITED LAB (03933): NOTIFICATION LETTER TO SHAREHOLDER AND REPLY FORM-
29.04.UNITED LAB (03933): FORM OF PROXY-
29.04.UNITED LAB (03933): NOTICE OF ANNUAL GENERAL MEETING-
29.04.UNITED LAB (03933): GENERAL MANDATES TO ISSUE SECURITIES AND REPURCHASE SHARES, RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING-
29.04.UNITED LAB (03933): 2024 ANNUAL REPORT1
15.04.UNITED LAB (03933): THE GROUP'S PRODUCT CEFOTAXIME SODIUM FOR INJECTION PASSED THE CONSISTENCY EVALUATION2
07.04.UNITED LAB (03933): VOLUNTARY ANNOUNCEMENT PROPOSED SHARE BUY-BACK UNDER GENERAL MANDATE1
26.03.UNITED LAB (03933): SPECIAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 202410
25.03.UNITED LAB (03933): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2024-
25.03.Chinese Biotech United Labs Grants Novo Nordisk Weight-Loss Drug Rights in USD2 Billion Deal36
25.03.Novo Nordisk gains rights to United Laboratories' triple receptor agonist in deal worth $2bn16
24.03.UNITED LAB (03933): 2024 ANNUAL RESULTS ANNOUNCEMENT8
24.03.Novo Nordisk A/S: The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist457Guangdong, China and Bagsværd, Denmark, 24 March 2025 -The United Laboratories International Holdings Limited (TUL) and Novo Nordisk A/S (Novo Nordisk) today announced that Novo Nordisk and TUL's wholly-owned...
► Artikel lesen
24.03.UNITED LAB (03933): VOLUNTARY ANNOUNCEMENT EXCLUSIVE LICENSE AGREEMENT WITH NOVO NORDISK2
21.03.UNITED LAB (03933): UPDATED INFORMATION ON THE GROUP'S PRODUCT LIRAGLUTIDE INJECTION1
21.03.UNITED LAB (03933): UPDATED INFORMATION ON THE GROUP'S PRODUCT POLYVINYL ALCOHOL EYE DROPS2
10.03.UNITED LAB (03933): DATE OF BOARD MEETING-
07.03.UNITED LAB (03933): THE GROUP'S PRODUCT CEFTRIAXONE SODIUM FOR INJECTION PASSED THE CONSISTENCY EVALUATION2
Weiter >>
25 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1